Trial Profile

An Open Label, Proof of Concept Study to Assess the Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PRX 106 (Primary)
Indications Ulcerative colitis
Focus Adverse reactions; Pharmacokinetics; Proof of concept
Sponsors Protalix Biotherapeutics

Most Recent Events

05 Jun 2018 Status changed from active, no longer recruiting to completed, based on the results presented at the Digestive Disease Week 2018.
05 Jun 2018 Results presented at the Digestive Disease Week 2018.
05 Jun 2018 Results presented in a Protalix BioTherapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com